Register
Zoledronic acid does not reduce knee pain in patients with knee OA |
Journal Updates
eMediNexus Coverage from: 
Zoledronic acid does not reduce knee pain in patients with knee OA
eMediNexus,  19 June 2018
remove_red_eye 557 Views
#Orthopedics #Rheumatology

0 Read Comments                

A study presented June 15, 2018 at EULAR 2018, the Annual European Congress of Rheumatology in Amsterdam has shown no benefit of zoledronic acid infusion in reducing knee pain or bone marrow lesion (BML) size overall in patients with knee osteoarthritis over the study period of two years.

To continue reading this article
Or

Continue reading your article with a Emedinexus account..
Free Membership!